Canada markets closed

Onconetix, Inc. (ONCO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.1165-0.0039 (-3.24%)
At close: 04:00PM EDT
0.1175 +0.00 (+0.86%)
After hours: 07:38PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.1204
Open0.1200
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1150 - 0.1220
52 Week Range0.1000 - 1.5800
Volume156,180
Avg. Volume690,257
Market Cap2.601M
Beta (5Y Monthly)3.38
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateMay 12, 2024 - May 16, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

    CINCINNATI, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) ("Onconetix" or the “Company”), a commercial stage biotechnology company focused on developing and commercializing therapeutics, diagnostics, and services for clinicians and patients in oncology, today announced the appointment of Ajit Singh, Ph.D. and Thomas Meier, Ph.D. to its Board of Directors. “We are thrilled to announce the addition of Dr. Singh and Dr. Meier to the Board of Directors of Onconetix,” stated Chair